All News

Anne Cassity, senior vice president of government affairs at NCPA, discusses the next moves of both PBMs and community pharmacy advocates following the signing of HR 7148.

As provisions begin rolling out over the next few years, community pharmacies will no longer be at the will of unfair reimbursement and contracting terms.

Pharmacists push for provider status and PBM overhaul as IRA policies squeeze pharmacies—what it means for access to vaccines, PrEP, and vital meds.

Pharmacists evolve from ancient healers to vital health care providers, enhancing patient care and accessibility in today's strained health system.

With President Trump’s signing of HR 7148, experts are now racing to get a grasp on the monumental shifts in pharmacy that will stem from this new legislation.

Pfizer's phase 2b study reveals promising results for its monthly GLP-1 therapy, enhancing weight loss and medication adherence in obesity management.

IBSA’s formulation of sildenafil, known as Vybrique, will hit the market in March 2026 as the first and only oral film that treats erectile dysfunction.

With infectious disease rates expected to jump as US vaccine schedules are reworked, antimicrobial stewardship programs are seeking community pharmacists.

John C. Goodman explores TrumpRx's initiatives to lower prescription drug prices, emphasizing direct-to-consumer purchasing and innovative employer strategies for savings.

Episode 7 dives into new standards of care from the American Diabetes Association and what updates are most important for pharmacists.

Through the perspectives of US health care plans and payers, researchers explore the differences in cost between single maintenance and reliever therapy and traditional therapies for treating asthma.

Pharmacogenomics enhances cardiometabolic disease management by personalizing medication based on genetic profiles, empowering pharmacists to optimize patient care.

Independent pharmacies navigate a transformative 2026, benefiting from increased PBM accountability and transparency, fostering a more stable operational landscape.

Inhaled Technosphere insulin revolutionizes diabetes management for children and pregnant women, addressing treatment adherence and psychological barriers effectively.

As lawmakers continue to deliberate on HR 7148, pharmacy law expert, Jesse Dresser, Esq, joined Drug Topics to discuss its provisions related to PBMs.

Pharmacists play a crucial role in managing complex medication regimens, ensuring safety and effectiveness for patients with behavioral health conditions.

Jari Becker, RPh, director of women’s health at Town & Country Compounding Pharmacy in Ramsey, New Jersey, shares how the pharmacy creates customized medications for patients all over the US.

Pharmacists enhance community health by providing vital services such as vaccinations and chronic disease management, despite facing reimbursement and recognition challenges.

Despite a significant leap in the development of asthma therapies, depression symptoms continue to be a roadblock for improved outcomes.

Pharmacists play a crucial role in managing polypharmacy, enhancing patient care through medication reconciliation and personalized therapy strategies.

A plant-based lifestyle intervention can lead to diabetes remission and weight loss, transforming traditional diabetes management strategies.

If signed by President Trump in time to avoid a government shutdown, HR 7148 has potential to enforce significant change in the prescription drug supply chain.

Pharmacists transform health care by offering essential services, tackling the opioid crisis, and adapting to new initiatives for better patient outcomes.

With a multitude of concerns surrounding corticosteroids for asthma, researchers explore the overall clinical and economic burden of these drugs.

High-dose vitamin D3 shows promise in improving metabolic health for type 2 diabetes patients, enhancing glycemic control alongside traditional treatments.

By uncovering insights on the regulatory framework regarding Rx-to-OTC rejections, researchers aim to address key challenges and concerns impeding self-care management.

This episode explores important insights on PBM reform and what pharmacies can look out for throughout 2026.

A recent survey reveals that over half of US patients face challenges with prescription costs, highlighting the need for better cost transparency and support.